Which has the lower trailing P/E, ICLR or UHS?

UHS has the lower trailing P/E: ICLR trades at 38.04 and UHS at 7.21. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ICLR or UHS?

Over the past five years, ICLR grew revenue faster — ICLR at a 20.93% CAGR versus UHS at 8.21%.

Does ICLR or UHS pay a bigger dividend?

UHS pays a dividend (0.46% yield), while ICLR has no payments in the available dividend history.

Is ICLR or UHS more profitable?

UHS runs the higher net margin — ICLR at 3.99% versus UHS at 8.42%.

How have ICLR and UHS total returns compared?

Over the past 10 years, ICLR delivered 7.67% and UHS delivered 4.06% annualized total return. Past performance doesn't predict future results.

ICON Public Limited Company (ICLR) vs Universal Health Services, Inc. (UHS)

A side-by-side comparison of ICON Public Limited Company and Universal Health Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 3, 2026. Differences are shown without an overall score or investment verdict.

ICLR

ICON Public Limited Company

$12.41B

$162.05HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

UHS

Universal Health Services, Inc.

$10.64B

$175.72HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — ICLR vs UHS

growth of $100 · dividends reinvested · last 10y

ICLR +109.4% (+7.7%/yr)UHS +51.6% (+4.2%/yr)ICLR compounded faster over this window

ICLR UHS

ICLR vs UHS: by the numbers

•ICLR is the larger company ($12.41B vs $10.64B market cap).
•UHS trades at the lower trailing earnings multiple (7.21 vs 38.04 P/E), one valuation lens rather than an overall verdict.
•UHS converts more revenue to profit (8.42% vs 3.99% net margin).
•ICLR grew revenue faster over the past five years (20.93% vs 8.21% CAGR).
•UHS pays a dividend (0.46% yield), while ICLR has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	ICLR	UHS
P/E ratio	38.04	7.21
Forward P/E	15.30	7.78
PEG ratio	N/A	0.45
P/S ratio	1.50	0.59
P/B ratio	1.32	1.42
EV / EBITDA	10.60	5.84
FCF yield	10.85%	7.77%

Profitability

Metric	ICLR	UHS
Gross margin	21.85%	90.69%
Operating margin	10.15%	11.36%
Net margin	3.99%	8.42%
ROE	3.51%	20.31%
ROIC	4.80%	11.74%

Dividends

Metric	ICLR	UHS
Dividend yield	N/A	0.46%
Payout ratio	N/A	3.28%

Growth (annualized)

Metric	ICLR	UHS
Revenue CAGR (5Y)	20.93%	8.21%
EPS CAGR (5Y)	-14.23%	16.19%
FCF CAGR (5Y)	22.10%	-12.18%
Total return CAGR (5Y)	-9.18%	5.37%

Frequently asked

Which has the lower trailing P/E, ICLR or UHS?: UHS has the lower trailing P/E: ICLR trades at 38.04 and UHS at 7.21. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ICLR or UHS?: Over the past five years, ICLR grew revenue faster — ICLR at a 20.93% CAGR versus UHS at 8.21%.
Does ICLR or UHS pay a bigger dividend?: UHS pays a dividend (0.46% yield), while ICLR has no payments in the available dividend history.
Is ICLR or UHS more profitable?: UHS runs the higher net margin — ICLR at 3.99% versus UHS at 8.42%.
How have ICLR and UHS total returns compared?: Over the past 10 years, ICLR delivered 7.67% and UHS delivered 4.06% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ICLR analysis Full UHS analysis Interactive comparison tool

Dig into the metrics

ICON Public P/E ratio Universal Health Services P/E ratio Universal Health Services dividend yield ICON Public ROE Universal Health Services ROE ICON Public operating margin Universal Health Services operating margin ICON Public revenue growth Universal Health Services revenue growth ICON Public free cash flow Universal Health Services free cash flow

ICON Public & Universal Health Services appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 3, 2026.